Roche shutters most trials of Alzheimer's drug after failed trials - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

United Kingdom News News

Roche shutters most trials of Alzheimer's drug after failed trials - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.
United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

Swiss drug-maker Roche is closing down most clinical trials of its experimental Alzheimer’s drug gantenerumab after it failed to slow advance of the mind-robbing disease in a pair of large, late-stage studies, the company said on Wednesday.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

The logo of Swiss drug-maker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.The logo of Swiss drug-maker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.

Both drugs are designed to remove forms of the protein beta amyloid from the brain, sticky plaques believed to play a major role in the disease. The field of Alzheimer’s research is littered with failure and disappointment, including for several drugs in the same class, and previous efforts to prove gantenerumab’s worth.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SABCNews /  🏆 37. in UK
 

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines



Render Time: 2025-01-15 19:09:51